AI & MACHINE LEARNING AGENTIC AI

TCS Reveals AgentHub: Audited Agentic AI for Drug Development

Techmediaglobal

| 4 min read

40%

CLINICAL DATA EFFICIENCY GAIN

30%

STUDY BUILD EFFORT REDUCTION

30%

ICSR COST SAVINGS

AI WORKER, ASSISTANT & TOOL TIERS

Tata Consultancy Services (TCS) has unveiled TCS ADD AgentHub, a platform built to embed specialised agentic AI directly into clinical operations and drug safety functions. Rather than offering generic productivity tools, AgentHub deploys a structured, role-based AI workforce that works alongside human experts on high-stakes pharmaceutical tasks — all within a framework of strict auditability and human oversight.

An AI Workforce Built for Compliance

In drug development, delays are often caused less by science and more by operational overhead. Highly regulated environments demand absolute auditability, leaving pharmaceutical companies caught between the promise of AI and the strict necessity of regulatory compliance.

Built on the established TCS ADD suite, AgentHub introduces AI Workers, Assistants, and Tools purpose-built for heavy-lifting tasks such as case intake, medical coding, quality review, literature analysis, and study support. Every action takes place inside a framework of strict human oversight and lifecycle control.

The shift isn't about replacing scientists — it's about freeing them from administrative burden so they can focus on higher-value scientific and medical decision-making.

"AgentHub helps organisations scale operations, reduce repetitive manual effort, improve consistency and enable experts to focus on higher-value scientific and medical decision-making"
— Rachna Malik, Global Head, TCS ADD — Life Sciences Platforms

Proven Impact, Not Experimental Promise

Unlike experimental AI tools still struggling to demonstrate business value, solutions running on AgentHub are already delivering measurable operational gains across key clinical data metrics — including up to 40% efficiency gains in clinical data management activities.

Other results include up to a 30% reduction in clinical study build effort through metadata-driven automation, and up to 30% cost savings in Individual Case Safety Report (ICSR) processing. These outcomes stem from years of enterprise deployments, with earlier generations of AI in production directly informing how AgentHub addresses past shortcomings in value realisation.

The Human and AI Collaborative Model

Underpinning the platform is a collaborative architecture in which intelligent agents manage embedded workflows while human professionals retain final control over critical medical and regulatory decisions. TCS says this hybrid approach gives life sciences enterprises a path to scale operations without taking on added compliance risk.

"TCS ADD AgentHub is an enterprise-ready, trusted AI platform that enables our customers to accelerate drug development using agentic AI at scale," says Debashis Ghosh, President of the Life Sciences, Health, Energy & Resources, and Utilities Business Group at TCS. "It enables a shift from reactive to proactive, scalable, and audit-ready operations amidst an ever-changing regulatory environment. TCS's strategy is to move toward autonomous enterprise functions where an AI workforce operates alongside humans to drive innovation and improve patient safety."

Key Takeaways

→TCS ADD AgentHub deploys role-based AI Workers, Assistants and Tools directly into pharmacovigilance and clinical operations.
→Every AI-driven action operates within a framework of human oversight, governance, auditability, and lifecycle control.
→Early deployments show up to 40% efficiency gains in clinical data management activities.
→Clinical study build effort can be reduced by up to 30% through metadata-driven automation.
→ICSR processing costs can drop by up to 30%, driven by agentic automation of case intake and coding.
→TCS positions AgentHub as a step toward autonomous enterprise functions, where AI and human experts work side by side to improve patient safety.

Tags: Agentic AI Healthcare Pharma TCS Drug Development Clinical Operations Pharmacovigilance Enterprise AI